Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    Illinois Masonic Chicago IL | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)
Condition: Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
Interventions: Device: NovoTTF-100M device;   Other: Best Standard of Care
2 Recruiting PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Conditions: Metastatic Renal Cell Carcinoma;   Metastatic Melanoma
Intervention:

Indicates status has not been verified in more than two years